Establishing a blood-based biomarker panel for pre-clinical Alzheimer’s disease [ 2018 - 2021 ]

Research Grant

Researchers: Dr Veer Bala Gupta (Principal investigator)

Brief description The current gold standard biomarkers for Alzheimer’s disease (AD) are uneconomical and invasive, thus impeding early treatment prior to irreversible damage. I posit that biochemical changes associated with the disease are reflected in the blood several years prior to the clinical manifestation of the disease. Therefore, I propose to investigate these changes in individuals predisposed to AD, prior to the appearance of clinical symptoms, to identify biomarkers for the early diagnosis of AD.

Funding Amount $AUD 726,812.86

Funding Scheme Targeted Calls

Notes Boosting Dementia Research Leadership Fellowship